Characterization of macrophage subpopulations and microvessel density in carcinomas of the gastrointestinal tract.

BACKGROUND The role of tumor associated macrophages (TAMs) in tumor angiogenesis and inflammation and the interactions between TAMs and tumor cells as well as lymphocytes appear to be critical factors in the development and progression of cancer. PATIENTS AND METHODS Carcinomas of the gastrointestinal tract have been analysed by tissue microarrays. TAMs and vessels were characterized by immunohistochemistry using the antibodies PG-M1, KP1, MRP8, MRP14, MRP8/14 and CD31, CD34, respectively. RESULTS The number of all macrophages was significantly higher and lymphocyte densities were lower in tumor tissues than in tumor-free tissues. The MRP-antibodies identified a minority population of macrophages and a low numbers of these macrophages tended to occur in more advanced cancers. There was a positive correlation between the number of macrophages and the number of microvessels in all tumors, but no correlation between macrophages and vessel counts in tumor-free tissues. CONCLUSION The results indicated a suppressed immune response towards the tumors. The observed common characteristics regarding macrophage attraction, lymphocyte suppression and microvessel density suggested that these mechanisms are regulated similarly in all carcinomas of the GI-tract.

[1]  S. Hauptmann,et al.  Macrophages and multicellular tumor spheroids in co-culture: a three-dimensional model to study tumor-host interactions. Evidence for macrophage-mediated tumor cell proliferation and migration. , 1993, American Journal of Pathology.

[2]  O. Eremin,et al.  Tumour-associated macrophages (TAMS): disordered function, immune suppression and progressive tumour growth. , 2000, Journal of the Royal College of Surgeons of Edinburgh.

[3]  P. Laakkonen,et al.  Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. , 2004, Journal of the American Society of Nephrology : JASN.

[4]  A. Frey,et al.  Tumor-Infiltrating Macrophages Induce Apoptosis in Activated CD8+ T Cells by a Mechanism Requiring Cell Contact and Mediated by Both the Cell-Associated Form of TNF and Nitric Oxide1 , 2001, The Journal of Immunology.

[5]  J A Sherratt,et al.  Modelling the macrophage invasion of tumours: effects on growth and composition. , 1998, IMA journal of mathematics applied in medicine and biology.

[6]  P. Allavena,et al.  Tumor-Associated Macrophages and Dendritic Cells as Prototypic Type II Polarized Myeloid Populations , 2003, Tumori.

[7]  A. Sica,et al.  Tumor-associated macrophages: a molecular perspective. , 2002, International immunopharmacology.

[8]  N. Freudenberg,et al.  Infiltration of lung carcinomas with macrophages of the 27E10-positive phenotype. , 1997, Lung cancer.

[9]  K. Alitalo,et al.  Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. , 2002, The American journal of pathology.

[10]  A. Harris,et al.  Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival , 2001, British Journal of Cancer.

[11]  H. Radzun,et al.  Expression of VCAM‐1, ICAM‐1, E‐ and P‐selectin and tumour‐associated macrophages in renal cell carcinoma , 2000, Histopathology.

[12]  R. Andreesen,et al.  Three‐dimensional co‐culture of human monocytes and macrophages with tumor cells: Analysis of macrophage differentiation and activation , 1996, International journal of cancer.

[13]  A. Harris,et al.  The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages , 2000 .

[14]  N. Minagawa,et al.  Relationships between tumor-associated macrophages and clinicopathological factors in patients with colorectal cancer. , 2002, Anticancer research.

[15]  K J O'Byrne,et al.  Chronic immune activation and inflammation as the cause of malignancy , 2001, British Journal of Cancer.

[16]  Marian Taylor,et al.  Relation of Hypoxia-inducible Factor-2α (HIF-2α) Expression in Tumor-infiltrative Macrophages to Tumor Angiogenesis and the Oxidative Thymidine Phosphorylase Pathway in Human Breast Cancer , 2002 .

[17]  P. Allavena,et al.  Cytokine regulation of monocyte recruitment. , 1995, Archivum immunologiae et therapiae experimentalis.

[18]  M. Goebeler,et al.  Expression and complex assembly of calcium‐binding proteins MRP8 and MRP14 during differentiation of murine myelomonocytic cells , 1993, Journal of leukocyte biology.

[19]  P. Allavena,et al.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2002, Trends in immunology.

[20]  D. Mullins,et al.  Tumor‐induced immune dysfunction: the macrophage connection , 1998, Journal of leukocyte biology.

[21]  F. Balkwill,et al.  The role of cytokines in the epithelial cancer microenvironment. , 2002, Seminars in cancer biology.

[22]  T. Wheeler,et al.  Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression. , 2000, Cancer research.

[23]  C. Kerkhoff,et al.  The Regulatory Role of MRP8 (S100A8) and MRP14 (S100A9) in the Transendothelial Migration of Human Leukocytes , 2000, Pathobiology.

[24]  A. Harris,et al.  Secretion of epidermal growth factor by macrophages associated with breast carcinoma , 1993, The Lancet.

[25]  G. Soma,et al.  Role of tumor-associated macrophage in malignant tumors: should the location of the infiltrated macrophages be taken into account during evaluation? , 2002, Anticancer research.

[26]  I. Takanami,et al.  Tumor-Associated Macrophage Infiltration in Pulmonary Adenocarcinoma: Association with Angiogenesis and Poor Prognosis , 1999, Oncology.

[27]  R. Hasina,et al.  Paracrine angiogenic loop between head‐and‐neck squamous‐cell carcinomas and macrophages , 2001, International journal of cancer.

[28]  T. Whiteside.  Immune responses to malignancies. , 2003, The Journal of allergy and clinical immunology.

[29]  Cord Sunderkötter,et al.  Macrophages and angiogenesis , 1994, Journal of leukocyte biology.

[30]  C. Kerkhoff,et al.  Binding of Two Nuclear Complexes to a Novel Regulatory Element within the Human S100A9 Promoter Drives the S100A9 Gene Expression* , 2002, The Journal of Biological Chemistry.

[31]  C. Lewis,et al.  Tumour‐associated leucocytes: Friends or foes in breast carcinoma , 1994, The Journal of pathology.

[32]  H. Ohtani,et al.  Cell Adhesion Molecule Expression by Vascular Endothelial Cells as an Immune/Inflammatory Reaction in Human Colon Carcinoma , 1995, Japanese journal of cancer research : Gann.

[33]  A. Harris,et al.  Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. , 1996, Cancer research.

[34]  H. Radzun,et al.  Expression of acute and late-stage inflammatory antigens, c-fms, CSF-1, and human monocytic serine esterase 1, in tumor-associated macrophages of renal cell carcinomas , 2000, Cancer Immunology, Immunotherapy.